Cambridge, MA, United States of America

David C Iannetta

USPTO Granted Patents = 4 

Average Co-Inventor Count = 6.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Cambridge, MA (US) (2020 - 2023)
  • Cambridge, MA (2024)

Company Filing History:


Years Active: 2020-2024

Loading Chart...
4 patents (USPTO):

Title: David C. Iannetta: Innovator in Corneal Treatment Technologies

Introduction

David C. Iannetta is a notable inventor based in Cambridge, MA (US), recognized for his contributions to the field of ophthalmology. He holds a total of 4 patents that focus on innovative systems and methods for treating corneal conditions. His work has significantly advanced the understanding and treatment of corneal cross-linking.

Latest Patents

Iannetta's latest patents include groundbreaking technologies such as "Systems and methods for determining cross-linking distribution in a cornea and/or structural characteristics of a cornea." This patent describes a corneal measurement system that utilizes an optical element to focus excitation light on corneal tissue. The system captures fluorescence emissions generated by a fluorescing agent applied to the cornea, allowing for precise measurements at various depths. Another significant patent is for "Micro-devices for treatment of an eye," which details a micro-device designed for corneal cross-linking treatment. This device features a unique body structure that creates a chamber over the cornea, enabling targeted delivery of photoactivating light to enhance cross-linking activity.

Career Highlights

David C. Iannetta is currently associated with Avedro, Inc., a company dedicated to developing advanced technologies for eye care. His innovative work has positioned him as a key figure in the field of corneal treatment, contributing to the development of effective solutions for patients with corneal issues.

Collaborations

Iannetta has collaborated with notable professionals in his field, including Desmond Christopher Adler and Jun Zhang. These collaborations have further enriched his research and development efforts, leading to advancements in corneal treatment technologies.

Conclusion

David C. Iannetta's contributions to ophthalmology through his patents and innovative technologies have made a significant impact on the treatment of corneal conditions. His work continues to inspire advancements in eye care and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…